Literature DB >> 15869805

Neuroinflammatory responses from microglia recovered from HIV-1-infected and seronegative subjects.

Anuja Ghorpade1, Yury Persidsky, Susan Swindells, Kathleen Borgmann, Raisa Persidsky, Spring Holter, Robin Cotter, Howard E Gendelman.   

Abstract

Microglial and macrophage infection and immune activation underlie the pathogenesis of HIV-1-associated dementia (HAD). To assess microglial function in HAD, we isolated cells from brain tissues recovered from an HIV-1-infected patient within 4 h of death. Brain tissue from seronegative patients served as controls. Regional neuropathology was correlated to microglial function. HIV-1-patient microglia formed multinucleated giant cells and produced progeny virions. These microglia secreted reduced basal and LPS-stimulated TNF-alpha levels compared to controls. Monocytes from seronegative donors paralleled these diminished immune responses following repeated LPS-activation. These results demonstrate changes in innate microglial function following viral infection or chronic immune activation.

Entities:  

Mesh:

Year:  2005        PMID: 15869805     DOI: 10.1016/j.jneuroim.2005.01.022

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  16 in total

1.  Preferential sensitivity of human dopaminergic neurons to gp120-induced oxidative damage.

Authors:  Shuxian Hu; Wen S Sheng; James R Lokensgard; Phillip K Peterson; R Bryan Rock
Journal:  J Neurovirol       Date:  2009-09       Impact factor: 2.643

2.  Morphine affects HIV-induced inflammatory response without influencing viral replication in human monocyte-derived macrophages.

Authors:  Rajnish S Dave
Journal:  FEMS Immunol Med Microbiol       Date:  2012-03

Review 3.  Cas9 Ribonucleoprotein Complex Delivery: Methods and Applications for Neuroinflammation.

Authors:  Lee A Campbell; Christopher T Richie; Nishad S Maggirwar; Brandon K Harvey
Journal:  J Neuroimmune Pharmacol       Date:  2019-06-06       Impact factor: 4.147

Review 4.  Fate of microglia during HIV-1 infection: From activation to senescence?

Authors:  Natalie C Chen; Andrea T Partridge; Christian Sell; Claudio Torres; Julio Martín-García
Journal:  Glia       Date:  2016-11-26       Impact factor: 7.452

Review 5.  Immunomodulatory properties of kappa opioids and synthetic cannabinoids in HIV-1 neuropathogenesis.

Authors:  Shuxian Hu; Wen S Sheng; Robert Bryan Rock
Journal:  J Neuroimmune Pharmacol       Date:  2011-08-18       Impact factor: 4.147

Review 6.  NeuroAIDS: characteristics and diagnosis of the neurological complications of AIDS.

Authors:  Alireza Minagar; Deborah Commins; J Steven Alexander; Romy Hoque; Francesco Chiappelli; Elyse J Singer; Behrooz Nikbin; Paul Shapshak
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

7.  In vitro modeling of HIV proviral activity in microglia.

Authors:  Lee A Campbell; Christopher T Richie; Yajun Zhang; Emily J Heathward; Lamarque M Coke; Emily Y Park; Brandon K Harvey
Journal:  FEBS J       Date:  2017-11-08       Impact factor: 5.542

Review 8.  NanoART, neuroAIDS and CNS drug delivery.

Authors:  Ari Nowacek; Howard E Gendelman
Journal:  Nanomedicine (Lond)       Date:  2009-07       Impact factor: 5.307

Review 9.  Immune activation in the central nervous system throughout the course of HIV infection.

Authors:  Serena S Spudich
Journal:  Curr Opin HIV AIDS       Date:  2016-03       Impact factor: 4.283

10.  Chronic Binge Alcohol-Associated Differential Brain Region Modulation of Growth Factor Signaling Pathways and Neuroinflammation in Simian Immunodeficiency Virus-Infected Male Macaques.

Authors:  John K Maxi; Don Mercante; Brittany Foret; Sarah Oberhelman; Tekeda F Ferguson; Gregory J Bagby; Steve Nelson; Angela M Amedee; Scott Edwards; Liz Simon; Patricia E Molina
Journal:  Alcohol Alcohol       Date:  2019-01-09       Impact factor: 2.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.